ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 67 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $343,000 | -33.1% | 131,912 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $513,000 | +44.1% | 131,912 | -0.2% | 0.00% | – |
| Q2 2016 | $356,000 | +1994.1% | 132,237 | +2239.6% | 0.00% | – |
| Q1 2016 | $17,000 | -26.1% | 5,652 | -3.7% | 0.00% | – |
| Q4 2015 | $23,000 | +35.3% | 5,867 | +3.3% | 0.00% | – |
| Q3 2015 | $17,000 | -29.2% | 5,681 | 0.0% | 0.00% | – |
| Q2 2015 | $24,000 | -91.5% | 5,681 | -92.3% | 0.00% | – |
| Q1 2015 | $283,000 | -42.2% | 73,324 | +0.6% | 0.00% | -100.0% |
| Q4 2014 | $490,000 | +21.3% | 72,861 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $404,000 | -45.1% | 73,614 | +2.6% | 0.00% | 0.0% |
| Q2 2014 | $736,000 | -4.7% | 71,758 | +11.6% | 0.00% | 0.0% |
| Q1 2014 | $772,000 | +5.9% | 64,316 | -0.2% | 0.00% | 0.0% |
| Q4 2013 | $729,000 | +3.6% | 64,436 | -1.4% | 0.00% | 0.0% |
| Q3 2013 | $704,000 | +39.4% | 65,352 | +19.9% | 0.00% | 0.0% |
| Q2 2013 | $505,000 | – | 54,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |